| Literature DB >> 25691945 |
Mohammad Saadatmandzadeh1, Mohammad Rahimizadeh1, Hossein Eshghi1, Mojtaba Sankian2.
Abstract
OBJECTIVES: In recent years, the chemistry of Tetrazolo[5',1':2,3][1,3,4]thiadiazepino [7,6-b] quinolines have received considerable attention owing to their synthetic and effective biological importance which exhibits a wide variety of biological activity. As the inhibitor of aldose reductase, the aforementioned compounds may have implication in preventing complications of diabetes.Entities:
Keywords: Aldose Reductase Inhibitors; Diabetes mellitus; Docking Analysis; Heterocyclic compound; Quinoline derivatives
Year: 2014 PMID: 25691945 PMCID: PMC4322152
Source DB: PubMed Journal: Iran J Basic Med Sci ISSN: 2008-3866 Impact factor: 2.699
Synthesis of tetrazolo[5',1':2,3][1,3,4] thiadiazepino[7,6-b]quinoline derivatives
| Product | R | Time (h) | Yield (%) |
|---|---|---|---|
| 3a | H | 7 | 96 |
| 3b | 8-Me | 6.5 | 92 |
| 3c | 8-OMe | 7 | 88 |
| 3d | 8-Et | 6 | 88 |
| 3e | 8-OEt | 8 | 95 |
| 3f | 8-Cl | 8 | 93 |
| 3g | 7-Me | 7.7 | 90 |
| 3h | 7-MeO | 7.5 | 88 |
| 3i | 8-Isopropyl | 8 | 85 |
Scheme 1
Scheme 2
Figure 1.The best docked structure of 3a in the active site pocket of ALR (PDB entry: 1AH3) in stick (left) and solvent surface (right) views
Estimated inhibitory constant (Ki), free energy of binding, GOLD score and amino acids involved in hydrogen binding with synthetic compounds
| Compound | GOLDscore | ΔG (kJ/mol) | Ki | Residues involved in hydrogen binding |
|---|---|---|---|---|
| 3a | 78.83 | -31.89 | 2.58E-06 | Trp 111-Tyr 209-His 110 |
| 3b | 75.71 | -28.91 | 8.60E-06 | Trp 111-Tyr 209-Asp 160 |
| 3c | 74.91 | -27.80 | 1.34E-05 | Trp 111-Tyr 209- |
| 3d | 75.91 | -28.72 | 9.29E-06 | Ser 210-Tyr 48 |
| 3e | 71.14 | -31.19 | 3.43E-06 | Trp 111-Tyr 209 |
| 3f | 76.88 | -29.44 | 6.95E-06 | Trp 111-Tyr 209-His 110 |
| 3g | 69.69 | -28.91 | 8.60E-06 | Trp 111-Tyr 209 |
| 3h | 73.05 | -28.44 | 1.04E-05 | Trp 111-Tyr 209-Asp 160 |
| 3i | 72.05 | -33.97 | 1.11E-06 | Tyr 48-Ser 210 |
| Tolrestat | 76.45 | -30.68 | 4.21E-06 | Tyr 48- His 110- Asp 160 |